Financhill
Sell
48

COLM Quote, Financials, Valuation and Earnings

Last price:
$76.61
Seasonality move :
4.95%
Day range:
$74.21 - $77.39
52-week range:
$73.04 - $92.88
Dividend yield:
1.57%
P/E ratio:
19.80x
P/S ratio:
1.33x
P/B ratio:
2.38x
Volume:
2.3M
Avg. volume:
944.6K
1-year change:
-2.72%
Market cap:
$4.2B
Revenue:
$3.4B
EPS (TTM):
$3.87

Earnings Data

Next earnings date for COLM
Apr 25
2025
Most recent earnings per share
$1.80
Missed by $0.08
(Feb 4/2025)
Consensus Estimate
$1.88
(Feb 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

COLM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/25/2025 Q1 $763.5M -- -- $0.66 --
02/04/2025 Q4 $1.1B $1.1B $1.80 $1.88 -$0.08
10/30/2024 Q3 $937.2M $931.8M $1.56 $1.36 $0.20
07/25/2024 Q2 $569.3M $570.2M -$0.20 -$0.33 $0.13
04/25/2024 Q1 $743.3M $770M $0.71 $0.37 $0.34
02/01/2024 Q4 $1.1B $1.1B $1.55 $1.96 -$0.41
10/26/2023 Q3 -- -- $1.70 $1.66 $0.04
08/01/2023 Q2 -- -- $0.14 $0.02 $0.12
04/27/2023 Q1 -- -- $0.74 $0.86 -$0.12
02/02/2023 Q4 -- -- $2.02 $2.29 -$0.27
10/27/2022 Q3 -- -- $1.80 $1.67 $0.13
07/27/2022 Q2 -- -- $0.11 $0.02 $0.09
04/28/2022 Q1 -- -- $1.03 $0.85 $0.18
02/03/2022 Q4 -- -- $2.39 $1.80 $0.59
10/28/2021 Q3 -- -- $1.52 $1.29 $0.23
08/02/2021 Q2 -- -- $0.61 -$0.09 $0.70
04/29/2021 Q1 -- -- $0.84 $0.39 $0.45
02/04/2021 Q4 -- -- $1.44 $1.29 $0.15
10/29/2020 Q3 -- -- $0.95 $1.26 -$0.31
07/30/2020 Q2 -- -- -$0.77 -$0.88 $0.11
04/30/2020 Q1 -- -- $0.00 $0.56 -$0.56
02/06/2020 Q4 -- -- $1.67 $1.66 $0.01
10/30/2019 Q3 -- -- $1.75 $1.55 $0.20
07/25/2019 Q2 -- -- $0.23 $0.03 $0.20
04/25/2019 Q1 -- -- $1.07 $0.83 $0.24
02/07/2019 Q4 -- -- $1.68 $1.28 $0.40
10/25/2018 Q3 -- -- $1.41 $1.28 $0.13
07/26/2018 Q2 -- -- $0.16 -$0.10 $0.26
04/26/2018 Q1 -- -- $0.77 $0.58 $0.19
02/08/2018 Q4 -- -- $1.31 $1.15 $0.16
10/26/2017 Q3 -- -- $1.28 $1.15 $0.13
07/27/2017 Q2 -- -- -$0.17 -$0.20 $0.03
04/27/2017 Q1 -- -- $0.51 $0.41 $0.10
02/09/2017 Q4 -- -- $1.20 $1.10 $0.10
10/27/2016 Q3 -- -- $1.18 $1.17 $0.01
07/28/2016 Q2 -- -- -- -- --
04/28/2016 Q1 -- -- $0.39 $0.32 $0.07
02/11/2016 Q4 -- -- $0.90 $0.77 $0.13
10/29/2015 Q3 -- -- $1.28 $1.07 $0.21
07/30/2015 Q2 -- -- -- -- --
04/30/2015 Q1 -- -- $0.37 $0.35 $0.02

Columbia Sportswear Earnings Questions

  • How Much did Columbia Sportswear Generate in Revenue Last Quarter?

    Columbia Sportswear reported $1.1B worth of top line sales in its most recent quarter.

  • Did Columbia Sportswear Beat Earnings Last Quarter?

    Columbia Sportswear announced earnings per share of $1.80 which represents a miss of analyst forecast a $1.88 per share.

  • Is Columbia Sportswear Profitable?

    Columbia Sportswear reported $560.5M that represents $9.86 per share over the last quarter.

  • What is the Analyst Consensus for Columbia Sportswear EPS Next Year?

    Columbia Sportswear's earnings are forecast to grow from $3.82 per share to $4.10 per share next year representing an increase of 7.24%.

  • When is Columbia Sportswear's Earnings Date?

    Columbia Sportswear's next earnings date is April 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock